Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Retinopathy.”

3,773 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 3,773 results

Not applicableLooking for participantsNCT01496625
What this trial is testing

National Eye Institute Biorepository for Retinal Diseases

Who this might be right for
Age-Related Macular DegenerationDiabetic RetinopathyVon Hippel-Lindau Syndrome+2 more
National Eye Institute (NEI) 650
Testing effectiveness (Phase 2)UnknownNCT02709876
What this trial is testing

Autologous Bone Marrow-Derived CD34+, CD133+, and CD271+ Stem Cell Transplantation for Retinitis Pigmentosa

Who this might be right for
Retinitis Pigmentosa
Stem Cells Arabia 50
Large-scale testing (Phase 3)Not Yet RecruitingNCT07082855
What this trial is testing

A Multicenter, Randomized, Double-Blind, Controlled Clinical Study of Minocycline for the Treatment of Retinitis Pigmentosa

Who this might be right for
Retinitis PigmentosaInherited Retinal DystrophyRetina Disorder
Zhongshan Ophthalmic Center, Sun Yat-sen University 126
Testing effectiveness (Phase 2)Active Not RecruitingNCT04634578
What this trial is testing

Bevacizumab Treatment For Type 1 ROP

Who this might be right for
Retinopathy of Prematurity
Jaeb Center for Health Research 77
Testing effectiveness (Phase 2)Ended earlyNCT02087085
What this trial is testing

A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Age-related Macular Degeneration

Who this might be right for
Geographic AtrophyMacular Degeneration
Allergan 310
Testing effectiveness (Phase 2)Study completedNCT04667910
What this trial is testing

601 Versus Ranibizumab in Patients With Central Retinal Vein Occlusion (CRVO)

Who this might be right for
Central Retinal Vein Occlusion
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 60
Not applicableStudy completedNCT01682382
What this trial is testing

Association of Macular Pigment Optical Density (MPOD) and Genetic Variants in Complement Factor H in Subjects With Choroidal Neovascular (CNV)

Who this might be right for
Age-related Macular DegenerationChoroidal Neovascular Age-related Macular Degeneration
Sequenom, Inc. 45
Not applicableNot Yet RecruitingNCT06333873
What this trial is testing

Impact of Age-related Macular Degeneration on Daily Living Activitie

Who this might be right for
Age-Related Macular Degeneration
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts 120
Not applicableStudy completedNCT02331173
What this trial is testing

Clinical Evaluation of Patients With X-linked Retinoschisis

Who this might be right for
X-linked RetinoschisisXLRS
Beacon Therapeutics 66
Large-scale testing (Phase 3)Study completedNCT01198327
What this trial is testing

Extended Follow-up of Patients With Macular Edema Due to Retinal Vein Occlusion

Who this might be right for
Retinal Vein Occlusion
Peter A Campochiaro, MD 66
Early research (Phase 1)Ended earlyNCT01334255
What this trial is testing

ISONEP to Treat Persistent Pigment Epithelial Detachment (PED) in Subjects With Exudative Age-Related Macular Degeneration (AMD) or Polypoidal Choroidal Vasculopathy (PCV)

Who this might be right for
Pigment Epithelial Detachment
Lpath, Inc. 12
Not applicableUnknownNCT04985448
What this trial is testing

Real World Study of the Effectiveness and Safety of Conbercept Ophthalmic Injection in the Treatment of Retinopathy of Prematurity - Multicenter, Retrospective and Observational Study Based on Real World Data

Who this might be right for
Retinopathy of Prematurity
Chengdu Kanghong Biotech Co., Ltd. 1,000
Not applicableEnded earlyNCT03935126
What this trial is testing

Global Atrophie Biomarker Evaluation Study (GABiE)

Who this might be right for
Age-related Macular Degeneration
Boehringer Ingelheim 3
Large-scale testing (Phase 3)Not Yet RecruitingNCT05750589
What this trial is testing

Safety and Tolerability of IRX-101 in Patients Receiving Intravitreal Injections

Who this might be right for
Retinal Disease
iRenix Medical, Inc. 240
Early research (Phase 1)UnknownNCT00476918
What this trial is testing

Intravitreal Triamcinolone Acetonide for Diabetic Macular Edema

Who this might be right for
Diabetic RetinopathyDiabetic Macular Edema
Heidelberg University 60
Not applicableUnknownNCT03104608
What this trial is testing

Automatic Self Transcending Meditation (ASTM) for Patients With Severe Age Related Macular Degeneration (AMD)

Who this might be right for
Age-related Macular DegenerationLow Vision
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 140
Large-scale testing (Phase 3)Study completedNCT07214740
What this trial is testing

Study to Evaluate a Pegcetacoplan (Syfovre®) Prefilled Syringe

Who this might be right for
Geographic Atrophy Secondary to Age-related Macular Degeneration
Apellis Pharmaceuticals, Inc. 44
Post-approval studies (Phase 4)Study completedNCT06416241
What this trial is testing

Intravitreal Aflibercept for Macular Edema Due to Central Retinal Vein Occlusion

Who this might be right for
Retinal Vein OcclusionVascular Occlusive Disease
University of Athens 51
Large-scale testing (Phase 3)Study completedNCT00000153
What this trial is testing

Krypton-Argon Regression of Neovascularization Study (KARNS)

Who this might be right for
Diabetic RetinopathyRetinal NeovascularizationDiabetes Mellitus
National Eye Institute (NEI)
Post-approval studies (Phase 4)Study completedNCT01710839
What this trial is testing

Widefield Angiography Guided Targeted-retinal Photocoagulation Combined With Anti VEgf Intravitreal Injections for the Treatment of Ischemic Central Retinal Vein Occlusion, Hemi Retinal Vein Occlusion, and Branch Retinal Vein Occlusion

Who this might be right for
Central Retinal, Hemi Retinal & Brach Retinal Vein Occlusions
Charles C Wykoff, PhD, MD 30
Load More Results